First Trust Nasdaq Pharmaceuticals ETF (FTXH) Short Interest Ratio & Short Volume $27.08 -0.03 (-0.11%) Closing price 07/25/2025 03:56 PM EasternExtended Trading$27.08 0.00 (0.00%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Short Interest DataFirst Trust Nasdaq Pharmaceuticals ETF (FTXH) has a short interest of 6,200 shares, representing 1.13% of the float (the number of shares available for trading by the public). This marks a -47.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 8,255 shares to cover all short positions.Current Short Interest6,200 sharesPrevious Short Interest11,700 sharesChange Vs. Previous Month-47.01%Dollar Volume Sold Short$158.91 thousandShort Interest Ratio0.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares550,000 sharesShort Percent of Float1.13%Today's Trading Volume1,168 sharesAverage Trading Volume8,255 sharesToday's Volume Vs. Average14% Short Selling First Trust Nasdaq Pharmaceuticals ETF? Sign up to receive the latest short interest report for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFTXH Short Interest Over TimeFTXH Days to Cover Over TimeFTXH Percentage of Float Shorted Over Time First Trust Nasdaq Pharmaceuticals ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20256,200 shares $158.91 thousand -47.0%1.1%0.4 $25.63 6/15/202511,700 shares $305.37 thousand +8.3%2.1%0.8 $26.10 5/31/202510,800 shares $276.36 thousand -10.0%1.3%1 $25.59 5/15/202512,000 shares $298.08 thousand +166.7%2.2%1.1 $24.84 4/30/20254,500 shares $116.08 thousand +1,400.0%N/A0.4 $25.80 4/15/2025300 shares $7.32 thousand -57.1%0.1%0.1 $24.39 3/31/2025700 shares $19.27 thousand +40.0%0.1%0.2 $27.53 3/15/2025500 shares $13.99 thousand -37.5%0.1%0.2 $27.97 2/28/2025800 shares $22.49 thousand +14.3%0.2%0.3 $28.11 2/15/2025700 shares $19.08 thousand -41.7%0.1%0.3 $27.25 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 1/31/20251,200 shares $33.29 thousand +33.3%N/A0.4 $27.74 1/15/2025900 shares $24.29 thousand -40.0%N/A0.4 $26.99 12/31/20241,500 shares $40.46 thousand +275.0%N/A0.6 $26.97 12/15/2024400 shares $10.92 thousand +100.0%N/A0.1 $27.29 11/30/2024200 shares $5.67 thousand -81.8%N/A0.1 $28.36 11/15/20241,100 shares $29.81 thousand -62.1%N/A0.3 $27.10 10/31/20242,900 shares $81.98 thousand +93.3%N/A0.8 $28.27 10/15/20241,500 shares $43.35 thousand +200.0%N/A0.4 $28.90 9/30/2024500 shares $14.42 thousand +66.7%N/A0.1 $28.84 9/15/2024300 shares $8.76 thousand -66.7%N/A0.1 $29.19 8/31/2024900 shares $26.69 thousand +200.0%N/A0.2 $29.66 8/15/2024300 shares $8.58 thousand -85.0%N/A0.1 $28.59 7/31/20242,000 shares $57.10 thousand +25.0%N/A0.4 $28.55 7/15/20241,600 shares $44.83 thousand No ChangeN/A0.3 $28.02 2/15/20241,000 shares $27.80 thousand -66.7%N/A0.1 $27.80 1/31/20243,000 shares $80.91 thousand -44.4%N/A0.4 $26.97 1/15/20245,400 shares $147.37 thousand +500.0%N/A0.7 $27.29 12/31/2023900 shares $23.95 thousand -35.7%N/A0.1 $26.62 12/15/20231,400 shares $36.65 thousand +1,300.0%N/A0.2 $26.18 11/30/2023100 shares $2.50 thousand -66.7%N/A0 $24.98 11/15/2023300 shares $7.37 thousand +200.0%N/A0 $24.56 10/31/2023100 shares $2.40 thousand -66.7%N/A0 $24.04 10/15/2023300 shares $7.68 thousand +50.0%N/A0 $25.61 9/30/2023200 shares $5.11 thousand -89.5%N/A0 $25.57 9/15/20231,900 shares $50.16 thousand -77.1%N/A0.2 $26.40 8/31/20238,300 shares $223.02 thousand +8,200.0%N/A0.6 $26.87 8/15/2023100 shares $2.71 thousand -66.7%N/A0 $27.05 7/31/2023300 shares $7.96 thousand -66.7%N/A0 $26.54 7/15/2023900 shares $23.42 thousand -76.3%N/A0.1 $26.02 6/30/20233,800 shares $99.52 thousand -28.3%N/A0.3 $26.19Elon Musk: “This will transform civilization as we know it.” (Ad)Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.Click here to see the robot stock that could dominate this revolution 6/15/20235,300 shares $140.82 thousand -15.9%N/A0.6 $26.57 5/31/20236,300 shares $161.03 thousand +6,200.0%N/A0.5 $25.56 5/15/2023100 shares $2.66 thousand -66.7%N/A0 $26.62 4/30/2023300 shares $7.98 thousand -25.0%N/A0 $26.60 4/15/2023400 shares $10.76 thousand -20.0%N/A0 $26.90 3/31/2023500 shares $13.05 thousand +400.0%N/A0 $26.10 3/15/2023100 shares $2.55 thousand -99.0%N/A0 $25.53 2/28/20239,500 shares $249.85 thousand -65.5%N/A0.7 $26.30 2/15/202327,500 shares $749.29 thousand +19.6%N/A2.4 $27.25 1/31/202323,000 shares $633.19 thousand -9.1%N/A2.1 $27.53 1/15/202325,300 shares $707.66 thousand +94.6%N/A2.1 $27.97 12/30/202213,000 shares $356.59 thousand -41.2%N/A0.9 $27.43 12/15/202222,100 shares $612.61 thousand -29.2%N/A1.7 $27.72 11/30/202231,200 shares $874.54 thousand +339.4%N/A2.4 $28.03 11/15/20227,100 shares $190.99 thousand +153.6%N/A0.6 $26.90 10/31/20222,800 shares $74.03 thousand +64.7%N/A0.2 $26.44 10/15/20221,700 shares $41.75 thousand No ChangeN/A0.1 $24.56 9/30/20223,700 shares $88.95 thousand -28.9%N/A0.2 $24.04 9/15/20225,200 shares $130.05 thousand -27.8%N/A0.1 $25.01 8/31/20227,200 shares $179.14 thousand -56.9%N/A0.1 $24.88 8/15/202216,700 shares $445.22 thousand +18.4%N/A0.3 $26.66 7/31/202214,100 shares $373.51 thousand +93.2%N/A0.3 $26.49 7/15/20227,300 shares $194.76 thousand No ChangeN/A0.2 $26.68 2/15/20226,100 shares $156.83 thousand -10.3%N/A2 $25.71 1/31/20226,800 shares $175.30 thousand -13.9%N/A2.2 $25.78 1/15/20227,900 shares $203.43 thousand -16.8%N/A2.5 $25.75 12/31/20219,500 shares $257.07 thousand +4.4%N/A3.4 $27.06 12/15/20219,100 shares $240.06 thousand +810.0%N/A3.5 $26.38 11/30/20211,000 shares $25.47 thousand -23.1%N/A0.4 $25.47 11/15/20211,300 shares $35.10 thousand +44.4%N/A0.3 $27.00 10/29/2021900 shares $23.61 thousand -18.2%N/A0.2 $26.23 10/15/20211,100 shares $28.46 thousand -15.4%N/A0.2 $25.87 9/30/20211,300 shares $33.53 thousand -51.9%N/A0.3 $25.79 9/15/20212,700 shares $69.74 thousand -30.8%N/A0.6 $25.83 8/31/20213,900 shares $104.05 thousand +11.4%N/A0.8 $26.68 8/13/20213,500 shares $93.35 thousand +9.4%N/A1.6 $26.67 7/30/20213,200 shares $84.45 thousand +18.5%N/A1.5 $26.39 7/15/20212,700 shares $69.39 thousand -20.6%N/A1 $25.70 6/30/20213,400 shares $87.99 thousand -71.2%N/A0.9 $25.88 6/15/202111,800 shares $307.63 thousand +35.6%N/A1.8 $26.07 5/28/20218,700 shares $224.44 thousand -3.3%N/A1.1 $25.80 5/14/20219,000 shares $231.32 thousand +20.0%N/A0.8 $25.70 4/30/20217,500 shares $195.21 thousand -40.5%N/A0.6 $26.03 4/15/202112,600 shares $324.39 thousand -44.0%N/A1 $25.75 3/31/202122,500 shares $566.78 thousand -12.5%N/A1.7 $25.19 3/15/202125,700 shares $675.65 thousand +30.5%N/A2.1 $26.29 2/26/202119,700 shares $516.14 thousand -21.2%N/A1.9 $26.20 2/12/202125,000 shares $668.63 thousand -3.9%N/A3.2 $26.75 1/29/202126,000 shares $690.30 thousand +10.2%N/A2.9 $26.55 1/15/202123,600 shares $634.60 thousand No ChangeN/A2.7 $26.89Elon Musk: “This will transform civilization as we know it.” (Ad)Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.Click here to see the robot stock that could dominate this revolution FTXH Short Interest - Frequently Asked Questions What is First Trust Nasdaq Pharmaceuticals ETF's current short interest? Short interest is the volume of First Trust Nasdaq Pharmaceuticals ETF shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 6,200 shares of FTXH short. 1.13% of First Trust Nasdaq Pharmaceuticals ETF's shares are currently sold short. Learn More on First Trust Nasdaq Pharmaceuticals ETF's current short interest. What is a good short interest percentage for First Trust Nasdaq Pharmaceuticals ETF? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.13% of First Trust Nasdaq Pharmaceuticals ETF's floating shares are currently sold short. Is First Trust Nasdaq Pharmaceuticals ETF's short interest increasing or decreasing? First Trust Nasdaq Pharmaceuticals ETF saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 6,200 shares, a drop of 47.0% from the previous total of 11,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does First Trust Nasdaq Pharmaceuticals ETF's short interest compare to its competitors? 1.13% of First Trust Nasdaq Pharmaceuticals ETF's shares are currently sold short. Here is how the short interest of companies compare to First Trust Nasdaq Pharmaceuticals ETF: JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (4.12%), Invesco Nasdaq Biotechnology ETF (0.32%), ProShares Ultra Nasdaq Biotechnology (0.57%), Invesco Dorsey Wright Healthcare Momentum ETF (0.25%), VanEck Biotech ETF (0.18%), VanEck Pharmaceutical ETF (41.19%), and iShares Biotechnology ETF (29.39%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short First Trust Nasdaq Pharmaceuticals ETF stock? Short selling FTXH is an investing strategy that aims to generate trading profit from First Trust Nasdaq Pharmaceuticals ETF as its price is falling. FTXH shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against First Trust Nasdaq Pharmaceuticals ETF? A short squeeze for First Trust Nasdaq Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FTXH, which in turn drives the price of the stock up even further. How often is First Trust Nasdaq Pharmaceuticals ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTXH, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies JDOC Short Squeeze BIS Short Squeeze IBBQ Short Squeeze BIB Short Squeeze PTH Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FTXH) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
